CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.58B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.49: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.61%Below 5Y avg (1.05%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
12.1%Sustainable
Last Ex-Dividend
Apr 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.69BCNY1.58B · vs all stocks (USD)
Trailing P/E
52.24xRevenue (TTM)
2.68BCNY397.52M · vs all stocks (USD)
Profit Margin
7.62%Beta
-0.1190xvs all stocks
52-Week Change
-25.06%vs all stocks
Market Capitalization
10.69BCNY1.58B · vs all stocks (USD)
Enterprise Value
11.67BCNY1.73B · vs all stocks (USD)
Trailing P/E
52.24xForward P/E
22.91xPrice to Sales (TTM)
4.02xPrice to Book (MRQ)
2.51xEnterprise to Revenue
4.35xEnterprise to EBITDA
20.64xGross Margin
53.13%Profit Margin
7.62%Operating Margin
14.23%Return on Assets (TTM)
2.67%Return on Equity (TTM)
3.19%Revenue (TTM)
2.68BCNY397.52M · vs all stocks (USD)
Revenue per Share (TTM)
3.25CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-8.80%Gross Profit (TTM)
1.41BCNY208.54M · vs all stocks (USD)
EBITDA (TTM)
304.93MCNY45.22M · vs all stocks (USD)
Net Income (TTM)
204.33MCNY30.30M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
35.20%Operating Cash Flow (TTM)
434.42MCNY64.42M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
36.01MCNY5.34M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0806CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.61%vs all stocks
5-Year Average Dividend Yield
1.05%vs all stocks
Payout Ratio
12.11%Minority Interest (Equity)
1.11BCNYFY2025 · Dec 31, 2025Revenue
2.74BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.34BCNYFY2025 · Dec 31, 2025Gross Profit
1.40BCNYFY2025 · Dec 31, 2025Operating Income
390.48MCNY57.91M · vs all stocks (USD)
Pre-tax Income
211.44MCNYFY2025 · Dec 31, 2025Income Tax Expense
57.00MCNYFY2025 · Dec 31, 2025Net Income
154.44MCNYFY2025 · Dec 31, 2025EBIT
348.98MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
561.82MCNYFY2025 · Dec 31, 2025Research & Development
232.61MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
432.52MCNYFY2025 · Dec 31, 2025Other Operating Expenses
53.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.17MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
137.54MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
154.44MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
41.19MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
339.86MCNYFY2025 · Dec 31, 2025Free Cash Flow
-20.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
844.73MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
154.44MCNYFY2025 · Dec 31, 2025Other Non-cash Items
162.14MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-53.99MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
77.28MCNYFY2025 · Dec 31, 2025Capital Expenditures
-360.28MCNYFY2025 · Dec 31, 2025Net Acquisitions
-115.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-1.35BCNYFY2025 · Dec 31, 2025Sale of Investments
1.15BCNYFY2025 · Dec 31, 2025Other Investing Activity
1.03MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-554.67MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
486.97MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-704.91MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-110.37MCNYFY2025 · Dec 31, 2025Other Financing Charges
414.62MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
86.32MCNYFY2025 · Dec 31, 2025Shares Outstanding
824.60MSharesUpdated Aug 19, 2026Float Shares
470.12MSharesUpdated Aug 19, 2026% Held by Insiders
41.89%vs all stocks
% Held by Institutions
5.76%vs all stocks
Total Cash (MRQ)
992.88MCNY147.24M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.20CNYUpdated Aug 19, 2026Total Debt (MRQ)
858.82MCNY127.36M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1589xCurrent Ratio (MRQ)
1.71xBook Value per Share (MRQ)
5.20CNYUpdated Aug 19, 2026Total Assets
9.22BCNY1.37B · vs all stocks (USD)
Total Current Assets
2.68BCNYFY2025 · Dec 31, 2025Total Liabilities
3.76BCNYFY2025 · Dec 31, 2025Total Non-current Assets
6.54BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.12BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.64BCNYFY2025 · Dec 31, 2025Cash
847.08MCNYFY2025 · Dec 31, 2025Cash Equivalents
23.67MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
870.75MCNYFY2025 · Dec 31, 2025Other Short-term Investments
225.22MCNYFY2025 · Dec 31, 2025Accounts Receivable
963.96MCNYFY2025 · Dec 31, 2025Inventory
532.57MCNYFY2025 · Dec 31, 2025Accounts Payable
583.93MCNYFY2025 · Dec 31, 2025Short-term Debt
317.86MCNYFY2025 · Dec 31, 2025Other Current Liabilities
13.70MCNYFY2025 · Dec 31, 2025Long-term Debt
437.74MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.22MCNYFY2025 · Dec 31, 2025Common Stock (Book)
824.60MCNYFY2025 · Dec 31, 2025Retained Earnings
1.50BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.46BCNY810.27M · vs all stocks (USD)
52-Week Low
12.05CNYUpdated Aug 19, 202652-Week High
18.10CNYUpdated Aug 19, 202652-Week Change
-25.06%vs all stocks
Beta
-0.1190xvs all stocks
50-Day MA
12.78CNYUpdated Aug 19, 2026200-Day MA
13.49CNYUpdated Aug 19, 2026Avg 10-Day Volume
8.71MSharesUpdated Aug 19, 2026Avg 30-Day Volume
9.63MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2500CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.53Profit Margin: 0.08
Financial Health
Altman Z-Score 2.49: grey zoneSignificant
Altman Z-Score: 2.49
High earnings qualityNotable
Earnings Quality Score: 1.40
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.58B, above the global median of $1.15BNotable
Market cap (USD): 1,584,846,557.829Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Intellia Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Vir Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Consun Pharmaceutical Group Limited
Tier 1ProductionApproval-Gated PipelineRule
Sihuan Pharmaceutical Holdings Group Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Harbin Gloria Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Forte Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ningbo Menovo Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Recursion Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Beijing Balance Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule